Prevalence of epilepsy in rural Bolivia
暂无分享,去创建一个
Vesna Sossi | Ali Samii | A. J. Stoessl | Zbigniew K. Wszolek | A. Samii | D. Calne | D. Miglioretti | A. Stoessl | E. Mak | T. Dobko | Edwin Mak | K. Markopoulou | K. Markopoulou | T. Dobko | D. B. Calne | V. Sossi | Z. Wszolek | R. P. Lesser | S.H. Kim | L. Beyderman | W. Webber | M. Bare | B. Cysyk | G. Krauss | B. Gordon
[1] G. Gregersen. Diabetic amyotrophy--a well-defined syndrome? , 2009, Acta medica Scandinavica.
[2] K. Gydell,et al. A rare type of femoral-sciatic neuropathy in diabetes mellitus. , 2009, Acta medica Scandinavica.
[3] W. Maier,et al. Diagnostic classification of psychiatric disorders and familial-genetic research , 1999, Dialogues in clinical neuroscience.
[4] Z. Wszolek,et al. Reduced expression of the G209A α‐synuclein allele in familial parkinsonism , 1999 .
[5] J. Jankovic,et al. Bruxism and cranial-cervical dystonia: is there a relationship? , 1999, Cranio : the journal of craniomandibular practice.
[6] J. Jankovic,et al. Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies , 1999, Journal of neurology, neurosurgery, and psychiatry.
[7] M. Daha,et al. Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates , 1999 .
[8] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[9] S. Saip,et al. Corticosteroid therapy augments gastroduodenal permeability to sucrose , 1998, American Journal of Gastroenterology.
[10] J. Jankovic,et al. Peripherally induced oromandibular dystonia , 1998, Journal of neurology, neurosurgery, and psychiatry.
[11] P. Schmitz,et al. The spectrum of antecedent infections in Guillain-Barré syndrome , 1998, Neurology.
[12] D. Luscombe,et al. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom , 1998, Journal of neurology, neurosurgery, and psychiatry.
[13] A. Hall,et al. A Neuroepidemiological Survey in Rural Bolivia: Background and Methods , 1998, Neuroepidemiology.
[14] P. Coyte,et al. Cost Analysis of Methylprednisolone Treatment of Multiple Sclerosis Patients , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[15] C. Marsden,et al. The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases , 1998 .
[16] C. Wilson,et al. Paired pulse suppression and facilitation in human epileptogenic hippocampal formation , 1998, Epilepsy Research.
[17] J. Olesen,et al. Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS , 1998, Neurology.
[18] N. Kohara,et al. Muscle afferent block for the treatment of oromandibular dystonia , 1998, Movement disorders : official journal of the Movement Disorder Society.
[19] Á. Pascual-Leone,et al. Study and modulation of human cortical excitability with transcranial magnetic stimulation. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[20] B. Peterson,et al. Course of Tic Severity in Tourette Syndrome: The First Two Decades , 1998, Pediatrics.
[21] I. Osorio,et al. Real‐Time Automated Detection and Quantitative Analysis of Seizures and Short‐Term Prediction of Clinical Onset , 1998, Epilepsia.
[22] F. Fera,et al. Randomized trial comparing two different high doses of methylprednisolone in MS A clinical and MRI study , 1998, Neurology.
[23] C. Hartmann,et al. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. , 1998, Archives of ophthalmology.
[24] M. Robertson,et al. The prevalence of Tourette syndrome in a mainstream school population , 1998, Developmental medicine and child neurology.
[25] F. Hsu,et al. GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid , 1998, Nature.
[26] W Paulus,et al. Transcranial magnetic stimulation: its current role in epilepsy research , 1998, Epilepsy Research.
[27] G. Krauss,et al. Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.
[28] M. Farrer,et al. Low frequency of α‐synuclein mutations in familial Parkinson's disease , 1998, Annals of neurology.
[29] C. Tanner,et al. Failure to find the a‐synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease , 1998, Neurology.
[30] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[31] D. Rubinow,et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. , 1998, The New England journal of medicine.
[32] J. Nutt,et al. Analysis of the α-synuclein G209A mutation in familial Parkinson's disease , 1998, The Lancet.
[33] W. Litchy,et al. Subacute diabetic proximal neuropathy. , 1997, Mayo Clinic proceedings.
[34] D. Lachar,et al. Tourette's syndrome and psychopathology in a child psychiatry setting. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[35] C. Kellner,et al. Electroconvulsive therapy for treatment of intractable seizures , 1997, Neurology.
[36] G. Grau,et al. Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis. , 1997, European cytokine network.
[37] P Jallon,et al. Epilepsy in Developing Countries , 1997, Epilepsia.
[38] H. Endtz,et al. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome , 1997, Journal of Neuroimmunology.
[39] Sube Banerjee,et al. Personality disorder and psychopathology in Tourette's syndrome: A controlled study , 1997, British Journal of Psychiatry.
[40] A. Marson,et al. The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability , 1997, Epilepsia.
[41] R S Fisher,et al. Assessment of vagus nerve stimulation for epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology , 1997, Neurology.
[42] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[43] D. C. Morley,et al. Managing measles. Size of infecting dose may be important. , 1997 .
[44] B. Jacobs,et al. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[45] C. Lacroix,et al. Painful proximal diabetic neuropathy: Inflammatory nerve lesions and spontaneous favorable outcome , 1997, Annals of neurology.
[46] R. Kurlan. Future direction of research in Tourette syndrome. , 1997, Neurologic clinics.
[47] K. Shannon,et al. Tongue Protrusion Dystonia: Treatment With Botulinum Toxin , 1997, Southern medical journal.
[48] M. Hallett,et al. Depression of motor cortex excitability by low‐frequency transcranial magnetic stimulation , 1997, Neurology.
[49] G. Koob,et al. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors , 1997 .
[50] W. Prodinger,et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. , 1997, Journal of immunology.
[51] N. Yuki,et al. Close association of Guillain–Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α , 1997, Journal of Neuroimmunology.
[52] M. Bouvy,et al. Applied Therapeutics: The Clinical Use of Drugs. , 1997, Pharmacy World and Science.
[53] J. Meulstee,et al. Electrodiagnostic findings related to anti‐GM1 and anti‐GQ1b antibodies in Guillain‐Barré syndrome , 1997, Muscle & nerve.
[54] S. Farmer,et al. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis , 1997, The Lancet.
[55] C. Woolley,et al. Estradiol Increases the Sensitivity of Hippocampal CA1 Pyramidal Cells to NMDA Receptor-Mediated Synaptic Input: Correlation with Dendritic Spine Density , 1997, The Journal of Neuroscience.
[56] H. Tsuji,et al. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. , 1997, The Journal of physiology.
[57] D J Burn,et al. Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study , 1997, Annals of neurology.
[58] T Eke,et al. Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.
[59] K. Leenders,et al. Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride , 1997, Movement disorders : official journal of the Movement Disorder Society.
[60] A. Kishore,et al. Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family , 1996, Neurology.
[61] J. Uhm,et al. Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9 , 1996 .
[62] E M Reiman,et al. The application of positron emission tomography to the study of the normal menstrual cycle. , 1996, Human reproduction.
[63] R. Mattson,et al. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy , 1996, Neurology.
[64] N. Yuki,et al. Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain—Barré syndrome subsequent to Campylobacter jejuni enteritis , 1996, Journal of Neuroimmunology.
[65] M. Robertson,et al. THE NATIONAL HOSPITAL INTERVIEW SCHEDULE FOR THE ASSESSMENT OF GILLES DE LA TOURETTE SYNDROME , 1996 .
[66] R. Mostafavi,et al. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. , 1996, The British journal of ophthalmology.
[67] M. Polymeropoulos,et al. Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.
[68] W. Neugebauer,et al. Structure-activity studies of B1 receptor-related peptides. Antagonists. , 1996, Hypertension.
[69] J. Rothwell,et al. Interaction between intracortical inhibition and facilitation in human motor cortex. , 1996, The Journal of physiology.
[70] L. Golbe,et al. Clinical genetic analysis of Parkinson's disease in the contursi kindred , 1996, Annals of neurology.
[71] H. Meinardi,et al. Epilepsy in the Tropics: I. Epidemiology, Socioeconomic Risk Factors, and Etiology , 1996, Epilepsia.
[72] L. Visser,et al. Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome , 1996, Annals of neurology.
[73] S. Chokroverty,et al. AAEM case report #13: Diabetic amyotrophy , 1996, Muscle & nerve.
[74] J. Hess,et al. The agonist selectivity of a mouse B1 bradykinin receptor differs from human and rabbit B1 receptors. , 1996, Immunopharmacology.
[75] G. Rosoklija,et al. Diabetic peripheral neuropathy: A clinicopathologic and immunohistochemical analysis of sural nerve biopsies , 1996, Muscle & nerve.
[76] R. Hilsden,et al. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. , 1996, Gastroenterology.
[77] D J Brooks,et al. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. , 1996, Brain : a journal of neurology.
[78] J. E. Mendizabal,et al. Prevalence of Epilepsy in a Rural Community of Guatemala , 1996, Epilepsia.
[79] J. Donoghue,et al. Long‐term Depression of Horizontal Connections in Rat Motor Cortex , 1996, The European journal of neuroscience.
[80] J. Holden,et al. Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[81] D. Brann,et al. Diverse modes of action of progesterone and its metabolites , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[82] H Scheich,et al. LTD and LTP induced by transcranial magnetic stimulation in auditory cortex , 1996, Neuroreport.
[83] A. Ahluwalia,et al. Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse. , 1996, Journal of immunology.
[84] S. Hauser,et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.
[85] J. French,et al. A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures , 1996, Neurology.
[86] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[87] R. Post,et al. Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. , 1995, Neuroreport.
[88] D. A. Krendel,et al. Successful treatment of neuropathies in patients with diabetes mellitus. , 1995, Archives of neurology.
[89] C. McDougle,et al. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[90] R. Pfeiffer,et al. A Greek‐American kindred with autosomal dominant, levodopa‐responsive parkinsonism and anticipation , 1995, Annals of neurology.
[91] Josep Maria Salanova Grau,et al. Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides , 1995, Annals of neurology.
[92] J. Meulstee,et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group. , 1995, Brain : a journal of neurology.
[93] S. M. Smith,et al. Auctioneer's jaw: A case of occupational oromandibular hemidystonia , 1995, Movement disorders : official journal of the Movement Disorder Society.
[94] P. V. D. Van den Bergh,et al. Five‐year experience in the treatment of focal movement disorders with low‐dose dysportTM botulinum toxin , 1995, Muscle & nerve.
[95] F. Marceau. Kinin B1 receptors: a review. , 1995, Immunopharmacology.
[96] W. Litchy,et al. Variables influencing neuropathic endpoints , 1995, Neurology.
[97] N. Yuki,et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome , 1995, Journal of the Neurological Sciences.
[98] P. Doorn,et al. Guillain‐Barré syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies , 1995, Annals of neurology.
[99] R. Kikkawa,et al. Antibodies against GM1 ganglioside affect K+ and NA+ currents in isolated rat myelinated nerve fibers , 1995, Annals of neurology.
[100] M. Mullen,et al. Oromandibular dystonia treated with botulinum toxin: report of case. , 1995, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[101] T. Owens,et al. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. , 1995, Neurologic clinics.
[102] R. Silva,et al. Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder. , 1995, Journal of child psychology and psychiatry, and allied disciplines.
[103] A. Broocks,et al. Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity , 1995, Annals of neurology.
[104] K. Gee,et al. Neuroactive Steroid Actions at the GABAA Receptor , 1994, Hormones and Behavior.
[105] M Schulzer,et al. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism , 1994, Annals of neurology.
[106] J. Nutt,et al. Increased risk of Parkinson's disease in parents and siblings of patients , 1994, Annals of neurology.
[107] K. Marder,et al. Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐ parkinsonism‐amyotrophy complex , 1994, Neurology.
[108] Muhammad Ishaq Khan,et al. Epilepsy in Pakistan: A Population‐Based Epidemiologic Study , 1994, Epilepsia.
[109] A. Antonini,et al. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease , 1994, Neurology.
[110] I. Kanazawa,et al. N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome , 1994, Annals of neurology.
[111] Mary M. Robertson,et al. Annotation: Gilles de la Tourette syndrome--an update. , 1994, Journal of child psychology and psychiatry, and allied disciplines.
[112] C. Lacroix,et al. Nerve biopsy findings in different patterns of proximal diabetic neuropathy , 1994, Annals of neurology.
[113] R. Kuzniecky,et al. Vagus Nerve Stimulation for Treatment of Partial Seizures: 3. Long‐Term Follow‐Up on First 67 Patients Exiting a Controlled Study , 1994, Epilepsia.
[114] B. Uthman,et al. Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability , 1994 .
[115] J. Wallace,et al. A simple, non-invasive marker of gastric damage: sucrose permeability , 1994, The Lancet.
[116] S. Seshadri,et al. Botulinum toxin A in blepharospasm and hemifacial spasm. , 1994, The Journal of the Association of Physicians of India.
[117] R. Lesser,et al. Electrical Stimulation and Language , 1994, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[118] D. Cohen,et al. Evidence Against a Genetic Relationship between Tourette's Syndrome and Anxiety, Depression, Panic and Phobic Disorders , 1994, British Journal of Psychiatry.
[119] R. Hughes,et al. Campylobacter jejuni and Guillain‐Barré syndrome , 1994, Annals of neurology.
[120] D. Bettucci,et al. Idiopathic Generalized Epilepsy: Magnetic Stimulation of Motor Cortex Time‐Locked and Unlocked to 3–Hz Spike‐and Wave Discharges , 1994, Epilepsia.
[121] C. Waters,et al. Autosomal dominant Lewy body parkinsonism in a four‐generation family , 1994, Annals of neurology.
[122] R. Beck,et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. , 1993, The New England journal of medicine.
[123] C. Marsden,et al. Familial parkinsonism with depression: A clinicopathological study , 1993, Annals of neurology.
[124] C. Marsden,et al. Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.
[125] M. Hamida,et al. Prevalence of Epilepsy in Kelibia, Tunisia , 1993, Epilepsia.
[126] M. Lawden,et al. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[127] I. Kanazawa,et al. Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome , 1993, Neurology.
[128] Orrin Devinsky,et al. Electrical and Magnetic Stimulation of the Brain and Spinal Cord , 1993 .
[129] H. Kimura,et al. Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.
[130] P A Low,et al. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. , 1993, Mayo Clinic proceedings.
[131] P C O'Brien,et al. Cool, warm, and heat‐pain detection thresholds , 1993, Neurology.
[132] B. Uthman,et al. Treatment of epilepsy by stimulation of the vagus nerve , 1993, Neurology.
[133] Prognosis. Guidelines for Epidemiologic Studies on Epilepsy , 1993, Epilepsia.
[134] M. Bear,et al. Common forms of synaptic plasticity in the hippocampus and neocortex in vitro. , 1993, Science.
[135] J. Wallace,et al. Sucrose: a novel permeability marker for gastroduodenal disease. , 1993, Gastroenterology.
[136] W. J. Litchy,et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.
[137] S. Kochar,et al. Meige's syndrome. , 1993, The Journal of the Association of Physicians of India.
[138] H. Willison,et al. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[139] R. Hughes,et al. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. , 1993, The Quarterly journal of medicine.
[140] G. Mwaluko,et al. Prevalence and Incidence of Epilepsy in Ulanga, a Rural Tanzanian District: A Community‐Based Study , 1992, Epilepsia.
[141] K. Nagashima,et al. Myelin Gangliosides of Human Peripheral Nervous System: An Enrichment of GM1 in the Motor Nerve Myelin Isolated from Cauda Equina , 1992, Journal of neurochemistry.
[142] A. E. Harding,et al. Parkinson's disease in twins studied with 18F‐dopa and positron emission tomography , 1992, Neurology.
[143] R P Lesser,et al. Placebo‐Controlled Pilot Study of Centromedian Thalamic Stimulation in Treatment of Intractable Seizures , 1992, Epilepsia.
[144] B. Snow,et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.
[145] N. Weiland. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. , 1992, Endocrinology.
[146] R S Fisher,et al. Motor and sensory cortex in humans: topography studied with chronic subdural stimulation. , 1992, Neurosurgery.
[147] R P Lesser,et al. Localization of sensorimotor cortex: the influence of Sherrington and Cushing on the modern concept. , 1992, Neurosurgery.
[148] Josemir W Sander,et al. Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. , 1992, Brain : a journal of neurology.
[149] M. Bear,et al. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[150] P. Schmitz,et al. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.
[151] M. Duchowny,et al. A safe and effective paradigm to functionally map the cortex in childhood. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[152] P. Lavados,et al. A descriptive study of epilepsy in the district of El Salvador, Chile, 1984–1988 , 1992, Acta neurologica Scandinavica.
[153] S. Staugaitis,et al. Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies , 1992, Annals of neurology.
[154] W. Rocca,et al. Validating screening instruments for neuroepidemiologic surveys: experience in Sicily. Sicilian Neuro-Epidemiologic Study (SNES) Group. , 1992, Journal of clinical epidemiology.
[155] K. Bhoola,et al. Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.
[156] Neil R. Miller,et al. A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .
[157] Richard S. J. Frackowiak,et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.
[158] F. Marceau,et al. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. , 1991, The Journal of pharmacology and experimental therapeutics.
[159] J. Mendell,et al. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. , 1991, Archives of neurology.
[160] P. Schmitz,et al. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.
[161] N. Hermanowicz,et al. Treatment of oromandibular dystonia with botulinum toxin , 1991, The Laryngoscope.
[162] J. McLean,et al. Castration alters susceptibility of male rats to specific seizures , 1991, Physiology & Behavior.
[163] L. Melton,et al. The Rochester Diabetic Neuropathy Study , 1991, Neurology.
[164] U. Müller,et al. The Phenotype of the X‐Linked Dystonia‐Parkinsonism Syndrome An Assessment of 42 Cases in the Philippines , 1991, Medicine.
[165] J. Jankovic,et al. Therapeutic uses of botulinum toxin. , 1991, The New England journal of medicine.
[166] W. Rocca,et al. Door-to-door prevalence survey of neurological diseases in a Sicilian population. Background and methods. The Sicilian Neuro-Epidemiologic Study (SNES) Group. , 1991, Neuroepidemiology.
[167] G. Barker,et al. Idiopathic blepharospasm-oromandibular dystonia syndrome (Meige's syndrome) presenting as chronic temporomandibular joint dislocation. , 1991, The British journal of oral & maxillofacial surgery.
[168] W. Hickey,et al. T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.
[169] T. Miyatake,et al. Acute axonal polyneuropathy associated with anti‐GM1 antibodies following Campylobacter enteritis , 1990, Neurology.
[170] W. Reeves,et al. Epidemiology of Epilepsy in Guaymi Indians from Bocas del Toro Province, Republic of Panama , 1990, Epilepsia.
[171] K. Nagashima,et al. Different Ceramide Compositions of Gangliosides Between Human Motor and Sensory Nerves , 1990, Journal of neurochemistry.
[172] C D Marsden,et al. Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.
[173] L. Wilkins. Assessment: The clinical usefulness of botulinum toxin‐A in treating neurologic disorders , 1990, Neurology.
[174] J. Jankovic,et al. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[175] M. Robertson,et al. Familial Tourette's Syndrome in a Large British Pedigree , 1990, British Journal of Psychiatry.
[176] J. Leckman,et al. Perinatal factors in the expression of Tourette's syndrome: an exploratory study. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.
[177] K. Kidd,et al. Segregation and linkage analyses of Tourette's syndrome and related disorders. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.
[178] Douglas C. Miller,et al. A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.
[179] C. Patlak,et al. Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.
[180] M. Bolger,et al. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one , 1989 .
[181] H. Wiśniewski,et al. Nerve regeneration patterns after acute ischemic injury , 1989, Neurology.
[182] D. Cohen,et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.
[183] T. Benstead,et al. Inner perineurial cell vulnerability in ischemia , 1989, Brain Research.
[184] M. Velasco,et al. Epileptiform EEG Activities of the Centromedian Thalamic Nuclei in Patients with Intractable Partial Motor, Complex Partial, and Generalized Seizures , 1989, Epilepsia.
[185] M. Robertson. The Gilles de la Tourette Syndrome: the Current Status , 1989, British Journal of Psychiatry.
[186] R. Kurlan. Difficulties in gene localization for Tourette's syndrome. Clinical aspects. , 1989, Molecular and chemical neuropathology.
[187] M. Brin,et al. Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia , 1989, The Annals of otology, rhinology, and laryngology.
[188] G. Alfieri,et al. Use of botulinum toxin in Meige's disease. , 1988, Rivista di neurologia.
[189] J. Kaprio,et al. Parkinson's disease in a nationwide twin cohort , 1988, Neurology.
[190] H. Lüders,et al. Localization of Cortical Function: New Information from Extraoperative Monitoring of Patients with Epilepsy , 1988, Epilepsia.
[191] J. Sipsey,et al. Are intravenous corticosteroids required in status asthmaticus? , 1988, JAMA.
[192] G. McKhann,et al. Serum antibodies to gangliosides in guillain‐barré syndrome , 1988, Annals of neurology.
[193] L. Gutmann,et al. Familial parkinsonism, apathy, weight loss, and central hypoventilation , 1988, Neurology.
[194] A. Bharucha,et al. Prevalence of Epilepsy in the Parsi Community of Bombay , 1988, Epilepsia.
[195] R. Koul,et al. Prevalence and Pattern of Epilepsy (Lath/Mirgi/Laran) in Rural Kashmir, India , 1988, Epilepsia.
[196] M. Trimble,et al. The Psychopathology of the Gilles de la Tourette Syndrome , 1988, British Journal of Psychiatry.
[197] J. Barabé,et al. Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis , 1988, Journal of the Neurological Sciences.
[198] M. Ahern,et al. Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? , 1988, Annals of the rheumatic diseases.
[199] J. Ferry,et al. Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses , 1988, Journal of clinical pharmacology.
[200] G. Erenberg,et al. The natural history of Tourette syndrome: A follow‐up study , 1987, Annals of neurology.
[201] P. Dyck,et al. Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination , 1987, Annals of neurology.
[202] M Velasco,et al. Electrical Stimulation of the Centromedian Thalamic Nucleus in the Treatment of Convulsive Seizures: A Preliminary Report , 1987, Epilepsia.
[203] R. Uitti,et al. Familial Parkinson's Disease: Possible Role of Environmental Factors , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[204] B. Osuntokun,et al. Prevalence of the Epilepsies in Nigerian Africans: A Community‐Based Study , 1987, Epilepsia.
[205] J Jankovic,et al. Botulinum A toxin for cranial‐cervical dystonia , 1987, Neurology.
[206] G. Klem,et al. Extraoperative Cortical Functional Localization in Patients with Epilepsy , 1987, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[207] C. Marsden. Parkinson's disease in twins. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[208] D. Cohen,et al. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. , 1986, Archives of general psychiatry.
[209] T. Peters,et al. Lactulose 51Cr-labelled ethylenediaminetetra-acetate, l-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability , 1986 .
[210] P. Thompson,et al. Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[211] J. Kidd,et al. Familial Tourette's syndrome , 1986, Neurology.
[212] R P Lesser,et al. Cortical Afterdischarge and Functional Response Thresholds: Results of Extraoperative Testing , 1984, Epilepsia.
[213] W. Bradley,et al. Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: A treatable inflammatory syndrome , 1984, Annals of neurology.
[214] T. Bäckström,et al. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy , 1984, Acta neurologica Scandinavica.
[215] D. Cohen,et al. A new instrument for clinical studies of Tourette's syndrome. , 1984, Journal of the American Academy of Child Psychiatry.
[216] A. Barbeau,et al. Familial Subsets in Idiopathic Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[217] D. Gajdusek,et al. Epilepsy in the Gbawein and Wroughbarh Clan of Grand Bassa County, Liberia: The Endemic Occurrence of 'See-ee' in the Native Population , 1983 .
[218] C. Elger,et al. Penicillin-induced epileptic foci in the motor cortex: vertical inhibition. , 1983, Electroencephalography and clinical neurophysiology.
[219] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[220] D. Gill,et al. Acute transient myositis of childhood , 1983, Irish journal of medical science.
[221] C. Ward,et al. Parkinson's disease in 65 pairs of twins and in a set of quadruplets , 1983, Neurology.
[222] J. Jankovic,et al. Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patients , 1983, Annals of neurology.
[223] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[224] S. Chokroverty. Proximal nerve dysfunction in diabetic proximal amyotrophy. Electrophysiology and electron microscopy. , 1982, Archives of neurology.
[225] R. Ruff,et al. Viral studies in benign acute childhood myositis. , 1982, Archives of neurology.
[226] Thomas Je,et al. Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients. , 1981 .
[227] P. Kellaway,et al. Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures , 1981, Epilepsia.
[228] A. Windebank,et al. Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination , 1981, Annals of neurology.
[229] G. Parry,et al. Arachidonate-induced experimental nerve infarction , 1981, Journal of the Neurological Sciences.
[230] E. Tolosa. Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases. , 1981, Archives of neurology.
[231] P. Dyck,et al. Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry , 1980, Annals of neurology.
[232] M. Farrell,et al. Epidemic influenza myopathy in Cincinnati in 1977. , 1980, The Journal of pediatrics.
[233] J. Snowdon. A comparison of written and postbox forms of the Leyton Obsessional Inventory , 1980, Psychological Medicine.
[234] H. Kessler,et al. Acute myopathy associated with influenza A/Texas/1/77 infection. Isolation of virus from a muscle biopsy specimen. , 1980, JAMA.
[235] A. Hays,et al. Isolation of influenza virus from muscle in myoglobinuric polymyositis , 1979, Neurology.
[236] W. H. Bradley. The American Academy of Otolaryngology , 1979 .
[237] P. Dyck,et al. Introduction of automated systems to evaluate touch‐pressure, vibration, and thermal cutaneous sensation in man , 1978, Annals of neurology.
[238] D. Prince,et al. Excitability changes in thalamocortical relay neurons during synchronous discharges in cat neocortex. , 1978, Journal of neurophysiology.
[239] J. Pirart. Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973 , 1978, Diabetes Care.
[240] E. Arciniegas,et al. Prevalence of epilepsy in Bogota, Colombia , 1978, Neurology.
[241] R. Buchta. Myositis and influenza. , 1977, Pediatrics.
[242] J. Giangiacomo,et al. 25-hydroxyvitamin D levels and rickets. , 1977, Pediatrics.
[243] S. Chokroverty,et al. The syndrome of diabetic amyotrophy , 1977, Annals of neurology.
[244] A. Asbury. Proximal diabetic neuropathy , 1977, Annals of neurology.
[245] M. Kashgarian,et al. Postviral myositis: myxovirus-like structures in affected muscle. , 1977, Annals of internal medicine.
[246] C. Marsden. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? , 1976, Journal of neurology, neurosurgery, and psychiatry.
[247] O. Creutzfeldt,et al. EEG changes during spontaneous and controlled menstrual cycles and their correlation with psychological performance. , 1976, Electroencephalography and clinical neurophysiology.
[248] J. Schaller,et al. Acute myositis associated with influenza B infection. , 1976, Pediatrics.
[249] I. R. Williams,et al. Subacute proximal diabetic neuropathy , 1976, Neurology.
[250] I. Mitchell,et al. Transient acute myositis in childhood. , 1976, Archives of disease in childhood.
[251] Joseph F. Williams. Annual Review of Pharmacology , 1975 .
[252] H. Wiśniewski,et al. Peripheral nerve ischemia Part 1. Experimental model , 1975, Journal of the Neurological Sciences.
[253] E. Ouellette,et al. The myositis of influenza. , 1973, Archives of neurology.
[254] S. Yen,et al. Serum Androstenedione and Testosterone Levels During the Menstrual Cycle , 1973 .
[255] P. Dyck,et al. Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels. , 1972, Mayo Clinic proceedings.
[256] P C O'Brien,et al. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. , 1971, Mayo Clinic proceedings.
[257] R. Beatty,et al. Orofacial dyskinesia. A dental dimension. , 1971, JAMA.
[258] D. Hoefnagel. Severe myositis during recovery from influenza. , 1970, Lancet.
[259] A. Asbury,et al. Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. , 1968, The New England journal of medicine.
[260] H. Kutt,et al. Intravenous diphenylhydantoin in treatment of acute repetitive seizures. 1968. , 1968, Neurology.
[261] A. Asbury,et al. Ischemic mononeuropathy multiplex associated with diabetes mellitus. , 1968, Archives of neurology.
[262] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[263] D. W. Mulder,et al. Femoral neuropathy , 1960, Neurology.
[264] H. Spiro,et al. Clinical and physiologic implications of the steroid-induced peptic ulcer. , 1960, The New England journal of medicine.
[265] Åke Lundberg. Myalgia Cruris Epidemica , 1957, Acta paediatrica.
[266] R.N.DeJ.. Epilepsy and the Functional Anatomy of the Human Brain , 1954, Neurology.
[267] E D Adrian,et al. The spread of activity in the cerebral cortex , 1936, The Journal of physiology.
[268] W. Gowers. A Manual of Diseases of the Nervous System , 1888, Atlanta Medical and Surgical Journal (1884).
[269] M. Daha,et al. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. , 1999, Annals of neurology.
[270] C. Norwood. Managed care reform--round one. , 1999, Cranio : the journal of craniomandibular practice.
[271] C. Tanner,et al. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. , 1998, Neurology.
[272] Letters-17 jan 1998 , 1998 .
[273] R. L. Moss,et al. Estrogen: nontranscriptional signaling pathway. , 1997, Recent progress in hormone research.
[274] R. Cheepsattayakorn,et al. Anti-E as a cause of hemolytic disease of the newborn. , 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[275] N. Poungvarin,et al. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients. , 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[276] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[277] R. L. Moss,et al. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. , 1996, Critical reviews in neurobiology.
[278] Q. Nguyen,et al. Bradykinin receptor types and B2 subtypes. , 1994, Life sciences.
[279] V. Torri,et al. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. , 1994, European neurology.
[280] M. Brin,et al. Oromandibular dystonia: Treatment of 96 patients with botulinum toxin A , 1994 .
[281] A. Berardelli,et al. Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: A multicenter study , 1994, Movement disorders : official journal of the Movement Disorder Society.
[282] Mark Hallett,et al. Therapy with botulinum toxin , 1994 .
[283] G. Román,et al. Epidemiology of epilepsy in developing countries. , 1993, Bulletin of the World Health Organization.
[284] L. Sedel,et al. A REPORT OF 17 CASES , 1993 .
[285] U Ruotsalainen,et al. PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.
[286] D. Brooks,et al. Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.
[287] J. Hall,et al. Bradykinin receptors: pharmacological properties and biological roles. , 1992, Pharmacology & therapeutics.
[288] R. Bruun,et al. The natural history of Tourette syndrome. , 1992, Advances in neurology.
[289] Bruun Rd,et al. The natural history of Tourette syndrome , 1992 .
[290] C. Marsden,et al. A clinical and genetic study of familial Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.
[291] S. Araki,et al. [Diabetic amyotrophy]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.
[292] D. Cornblath,et al. Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.
[293] S. Hodge,et al. Twin studies and the genetics of Parkinson's disease—a reappraisal , 1990, Movement disorders : official journal of the Movement Disorder Society.
[294] I. Check,et al. Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. , 1989, Critical reviews in clinical laboratory sciences.
[295] K. Obata,et al. Improved method for large-scale purification of brain gangliosides by Q-sepharose column chromatography. Immunochemical detection of C-series polysialogangliosides in adult bovine brains. , 1988, Journal of chromatography.
[296] J. Patrinely,et al. Local side effects of botulinum toxin injections. , 1988, Advances in neurology.
[297] H. Klawans,et al. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). , 1988, Advances in neurology.
[298] E. Tolosa,et al. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects. , 1988, Advances in neurology.
[299] S. Fahn,et al. Analysis of open‐label trials in torsion dystonia using high dosages of anticholinergics and other drugs , 1988, Movement disorders : official journal of the Movement Disorder Society.
[300] Klawans Hl,et al. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). , 1988 .
[301] M. Brin,et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm , 1987, Movement disorders : official journal of the Movement Disorder Society.
[302] Diane C. Tsai. Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.
[303] J. Rapoport,et al. The Leyton Obsessional Inventory--Child Version. , 1985, Psychopharmacology bulletin.
[304] P. Dyck,et al. Microsphere embolization of nerve capillaries and fiber degeneration. , 1984, The American journal of pathology.
[305] R. Yu,et al. Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.
[306] S. Hakomori. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.
[307] P. Birleson. The validity of depressive disorder in childhood and the development of a self-rating scale: a research report. , 1981, Journal of child psychology and psychiatry, and allied disciplines.
[308] U. Slager. Diabetic myelopathy. , 1978, Archives of pathology & laboratory medicine.
[309] S. Chokroverty,et al. Bruns-Garland syndrome of diabetic amyotrophy. , 1977, Transactions of the American Neurological Association.
[310] J. Melby. Clinical pharmacology of systemic corticosteroids. , 1977, Annual review of pharmacology and toxicology.
[311] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .